Skip to main content

Peer Review reports

From: Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer

Original Submission
8 Feb 2020 Submitted Original manuscript
16 Apr 2020 Reviewed Reviewer Report
19 Jun 2020 Reviewed Reviewer Report - Roberto A Scatena
26 Sep 2020 Author responded Author comments - Jun Li
Resubmission - Version 2
26 Sep 2020 Submitted Manuscript version 2
21 Oct 2020 Reviewed Reviewer Report
27 Oct 2020 Author responded Author comments - Jun Li
Resubmission - Version 3
27 Oct 2020 Submitted Manuscript version 3
18 Nov 2020 Reviewed Reviewer Report
29 Nov 2020 Author responded Author comments - Jun Li
Resubmission - Version 4
29 Nov 2020 Submitted Manuscript version 4
30 Dec 2020 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
2 Jan 2021 Editorially accepted
14 Jan 2021 Article published 10.1186/s12885-021-07785-w

You can find further information about peer review here.

Back to article page